Assoc. Prof. Dr. Halil Ibrahim Erdoğdu - infectious diseases - Excellence in Research

Kafkas University - Turkey

Author Profile

🎓 Early academic pursuits

Halil Ibrahim Erdoğdu began his journey in medicine at dicle university faculty of medicine, where he studied from 1985 to 1991. after graduating in 1991, he pursued specialization in internal medicine between 1994 and 1998. his early academic focus laid the foundation for his future contributions to internal medicine, nephrology, and immunology, drawing interdisciplinary parallels with advanced technological systems like power electronics, emphasizing precision and control in medical interventions.

🏥 Professional endeavors

Following his specialization, dr. erdoğdu served at kars state hospital from 1998 to 2015, significantly impacting regional healthcare. since 2015, he has been a dedicated clinician and educator at the internal medicine clinic of kafkas university. his clinical excellence is paired with responsibilities as the statistics editor for the kafkas journal of medical sciences, showcasing his dual focus on patient care and academic quality, much like the regulated flow in power electronics systems ensuring efficiency and stability.

🔬 Contributions and research focus

Dr. Erdoğdu’s research concentrates on immunology, hemodialysis, and infectious diseases. his notable studies include the evaluation of vaccine responses in hemodialysis patients and elderly populations, such as the investigation into the level of response to covid-19 vaccine in hemodialysis patients. these studies aim to enhance public health through data-driven insights, infectious diseases integrating methodologies akin to diagnostic precision in power electronics—optimizing performance through feedback mechanisms and individual-based adaptation.

🌍 Impact and influence

With publications in renowned journals such as clinical and experimental nephrology, heart lung and circulation, and current microbiology, dr. erdoğdu's work has influenced both national and international academic communities. his research on vaccine efficacy and public awareness contributes significantly to patient education and public health planning, especially in high-risk infectious diseases groups like the elderly and those undergoing dialysis.

📚 Academic citations

Dr. Erdoğdu’s scientific contributions are reflected in his academic impact, with an h-index of 6 and i-10 index of 5 according to google scholar. his scopus author profile (id: 57190609988) also infectious diseases confirms a solid record of peer-reviewed research, further affirming his role in advancing internal medicine research.

🛠️ Legacy and future contributions

With several published books (isbn: 978-625-8065-78-7, 978-625-8324-24-2, among others) and continuing engagement in research, dr. erdoğdu is committed to mentoring new professionals and enhancing the scientific community’s understanding of immunological responses and chronic disease management. his future work is expected to integrate more translational research, further linking theoretical knowledge with practical application in clinical settings.

Notable Publications

Title: Can complete blood cell count parameters predict deep vein thrombosis? / Mogu li parametri kompletne krvne slike predvidjeti duboku vensku trombozu?
Authors: Tural, K.; Kara, F.; Avcı, S.; Erdoğdu, H.İ.
Journal: Acta Clinica Croatica (2020)
Title: Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast Anatolia survey with six hemodialysis centers
Authors: Erdoğdu, H.İ.; Atalay, E.; Gürsoy, G.; Canbakan, B.; Aktürk, S.; Yazıcı, C.; Yücel, O.; Mersin, S.; Üçer, S.; Merhametsiz, Ö. et al.
Journal: Clinical and Experimental Nephrology (2019)
Title: Hypoalbuminemia and related factors in hemodialyzed patients: A study of six centers in Turkey / Hemodiyaliz hastalarında hipoalbüminemi ve ilişkili faktörler: Türkiye’de altı merkezli bir çalışma
Authors: Erdoğdu, H.İ.; Atalay, E.
Journal: Haseki Tip Bulteni (2019)
Title: The C-Reactive Protein to Albumin Ratio Predicts Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Authors: Karabağ, Y.; Çağdaş, M.; Rencuzogullari, I.; Karakoyun, S.; Artaç, İ.; İliş, D.; Yesin, M.; Çiftçi, H.; Erdoğdu, H.I.; Tanboğa, I.H.
Journal: Heart Lung and Circulation (2019)
Title: The relationship between C-reactive protein/albumin ratio and 1-year mortality in hospitalized elderly COPD patients with acute exacerbation / Akut KOAH atağı ile hastaneye yatırılan yaşlı hastalarda 1 yıl mortalite ile C-reaktif protein/albumin oranı arasındaki ilişkinin değerlendirilmesi
Authors: Atalay, E.; Erdoğdu, H.İ.; Tur, B.K.; Deniz Balyen, L.S.; Karabağ, Y.; Ardiç, S.
Journal: Turk Geriatri Dergisi (2019)

🌱 Early academic pursuits

Atsushi Hinenoya embarked on his academic journey with a deep passion for veterinary science and microbiology. he earned his ph.d. in 2009 from the department of veterinary science at the graduate school of life and environmental sciences, osaka prefectural university, japan. during this time, he delved into complex microbial research, laying the foundation for his career as an esteemed microbiologist and academic leader.

🏫 Professional endeavors

Dr. Hinenoya’s professional career began in 2009 as an assistant professor at osaka prefectural university, where he dedicated nearly a decade to teaching and research. his commitment and expertise earned him a promotion to associate professor in 2017. between 2017 and 2019, he expanded his international experience as a visiting scholar at the department of animal science, university of tennessee, usa. in 2022, he joined osaka metropolitan university as an associate professor in the department of veterinary science, where he continues to contribute to advancing veterinary microbiology.

🔬 Contributions and research focus

Throughout his career, dr. hinenoya has focused on understanding zoonotic pathogens, specifically escherichia coli and escherichia albertii. his completed research projects have addressed Molecular epidemiology of pathogenic bacteria molecular epidemiology, colistin resistance, and horizontal gene transfer in e. coli. currently, his ongoing studies aim to develop novel detection methods, analyze virulence mechanisms, and explore the transmission dynamics of e. albertii. his contributions to the field are evident through his published works and two patents, including an innovative method for producing disinfected liver.

🏆 Accolades and recognition

Dr. Hinenoya’s groundbreaking research has earned him several prestigious awards. he received research encouragement awards in 2011 and 2016 from the japanese symposium for Molecular epidemiology of pathogenic bacteria enterohemorrhagic e. coli infectious diseases. in 2021, he was honored with the young scientist award by the japanese society for bacteriology, further solidifying his reputation as a leader in the field of bacteriology.

🌍 Impact and influence

With a citation index of 26 in scopus, dr. hinenoya’s work has significantly influenced the scientific community, particularly in veterinary microbiology and zoonotic pathogen research. his Molecular epidemiology of pathogenic bacteria consultancy projects with taiko pharmaceutical have contributed to the development of effective disinfection methods against multidrug-resistant bacteria and foodborne pathogens, demonstrating the practical application of his research in public health and food safety.

💡 Legacy and future contributions

Dr. Hinenoya’s legacy lies in his unwavering commitment to combating zoonotic diseases and advancing veterinary microbiology. as he continues his research on e. albertii and other emerging pathogens, his work promises to shape the future of microbial science and public health. his dedication to mentoring young scientists and collaborating with international institutions ensures that his contributions will have a lasting impact on the field.

Notable Publications

Title: Occurrence and cross contamination of Escherichia albertii in retail chicken outlets in Bangladesh
Authors: Hassan, J., Utsho, K.S., Karmakar, S., Yamasaki, S., Hinenoya, A.
Journal: International Journal of Food Microbiology, 2025, 431, 111081

Title: Prevalence of potentially pathogenic and antimicrobial-resistant Escherichia coli in raw milk and dairy products in Egypt
Authors: Elbastawesy, A.M., Awasthi, S.P., Hatanaka, N., Deeb, A.M.M., Yamasaki, S.
Journal: International Dairy Journal, 2025, 162, 106145

Title: Development of a novel modified selective medium cefixime–tellurite-phosphate-xylose-rhamnose MacConkey agar for isolation of Escherichia albertii and its evaluation with food samples
Authors: Takehira, K., Manjunath, G.B., Hatanaka, N., Hinenoya, A., Yamasaki, S.
Journal: International Journal of Food Microbiology, 2025, 430, 111057

Title: A plasmid-mediated type III secretion system associated with invasiveness and diarrheagenicity of Providencia rustigianii
Authors: Hassan, J., Hinenoya, A., Hatanaka, N., Faruque, S.M., Yamasaki, S.
Journal: mBio, 2024, 15(10)

Title: Detection of prolonged excretion of Escherichia albertii in stool specimens of a 7-year-old child by a newly developed Eacdt gene-based quantitative real-time PCR method and molecular characterization of the isolates
Authors: Awasthi, S.P., Nagita, A., Hatanaka, N., Hinenoya, A., Yamasaki, S.
Journal: Heliyon, 2024, 10(9), e30042